(Q35000581)

English

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities (English)

1 reference

Europe PubMed Central

5 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

13

object named as

Rainer Storb

1 reference

Europe PubMed Central

5 August 2017

Brenda M Sandmaier

11

object named as

Brenda M Sandmaier

1 reference

Europe PubMed Central

5 August 2017

Frederick R. Appelbaum

14

object named as

Frederick R Appelbaum

1 reference

Europe PubMed Central

5 August 2017

Hans Joachim Deeg

15

object named as

H Joachim Deeg

1 reference

Europe PubMed Central

5 August 2017

8

object named as

Paul J Martin

1 reference

Europe PubMed Central

5 August 2017

Mohamed L Sorror

3

object named as

Mohamed L Sorror

1 reference

Europe PubMed Central

5 August 2017

5

object named as

Bart L Scott

1 reference

Europe PubMed Central

5 August 2017

Kristine C Doney

6

object named as

Kristine Doney

1 reference

Europe PubMed Central

5 August 2017

10

object named as

Jerry P Radich

1 reference

Europe PubMed Central

5 August 2017

author name string

Hesham Eissa

1

1 reference

Europe PubMed Central

5 August 2017

Ted A Gooley

2

1 reference

Europe PubMed Central

5 August 2017

Franchesca Nguyen

4

1 reference

Europe PubMed Central

5 August 2017

Keith R Loeb

7

1 reference

Europe PubMed Central

5 August 2017

John M Pagel

9

1 reference

Europe PubMed Central

5 August 2017

E Houston Warren

12

1 reference

Europe PubMed Central

5 August 2017

publication date

6 October 2010

1 reference

Europe PubMed Central

5 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

5 August 2017

17

1 reference

Europe PubMed Central

5 August 2017

6

1 reference

Europe PubMed Central

5 August 2017

908-915

1 reference

Europe PubMed Central

5 August 2017

Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

8 July 2018

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

[Clinical features of a new category, myelodysplastic/myeloproliferative diseases, defined by WHO classification].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100432

26 October 2018

Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myelomonocytic leukemia in the light of the WHO proposals

1 reference

https://pubmed.ncbi.nlm.nih.gov/20932924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2010.09.018

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35000581&oldid=1988058661"